Haw Par Corporation Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Haw Par Corporation Limited with three other
pharmaceutical manufacturers in Asia:
Jiuzhitang Company Limited
sales of 871.46 million Chinese Renmimbi [US$127.13 million]
of which 97%
was Pharmacuetical Industry),
Indoco Remedies Ltd
(8.57 billion Indian Rupees [US$126.31 million]
of which 100%
was Pharmaceuticals), and
Whanin Pharmaceutical Company Limited
based in South Korea
(145.40 billion Korean Won [US$125.19 million]
Haw Par Corporation Limited reported sales of 178.83 million Singapore Dollars (US$126.38 million)
December of 2015.
increase of 16.0%
versus 2014, when the company's sales were 154.22 million Singapore Dollars.
Sales at Haw Par Corporation Limited have increased during each of the previous five years
(and since 2010, sales have increased a total of 38%).
Sales of Healthcare Products saw an increase
24.8% in 2015, from
122.23 million Singapore Dollars to 152.57 million Singapore Dollars.
Not all segments of Haw Par Corporation Limited experienced an increase in sales in 2015:
sales of Leisure Products and Services fell 18.4% to 12.74 million Singapore Dollars.
Haw Par Corporation Limited also experienced decreases in sales in
Property Rental (down 17.4% to 13.53 million Singapore Dollars)